The Lancet Oncology in conversation with

Roberto Orecchia on the ELIOT trial

The Lancet Oncology

Roberto Orecchia (European Institute of Oncology IRCCS) discusses the ELIOT trial on intraoperative irradiation for early breast cancer.

Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00080-2/fulltext

Tell us what you thought about this episode

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv